Skip to main navigation
Skip to search
Skip to main content
Research Profiles at Washington University School of Medicine Home
Help & FAQ
Home
Profiles
Departments, Divisions and Centers
Research output
Search by expertise, name or affiliation
Importance of comorbidity in head and neck cancer
Jay F. Piccirillo
Department of Otolaryngology
Institute of Clinical and Translational Sciences (ICTS)
Siteman Cancer Center
COVID-19 Researchers
Institute for Public Health
Research output
:
Contribution to journal
›
Article
›
peer-review
355
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Importance of comorbidity in head and neck cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Comorbidity
100%
Head-and-neck Cancer
100%
Lung
22%
Cancer Patients
22%
Initial Treatment
16%
Prostate
16%
Breast
16%
Patients with Cancer
16%
Overall Survival
11%
Patient Care
11%
Head-and-neck
11%
Treatment Efficacy
11%
Colorectum
11%
Severe Comorbidity
11%
Treatment Evaluation
11%
Tumor
5%
Multivariable
5%
Illness
5%
Moderate to Severe
5%
Staging System
5%
Medical Records
5%
Prospective Cohort Study
5%
Logistic Regression Analysis
5%
TNM Staging
5%
Prognostic Impact
5%
Prognostic Significance
5%
Patient Selection
5%
New Patients
5%
Age-stage
5%
Comorbidity Burden
5%
Teaching Hospital
5%
Significant Relationship
5%
Log-rank Test
5%
Statistical Techniques
5%
Direct Impact
5%
Scientific Assessment
5%
Comorbidity Index
5%
Systems-based
5%
TNM System
5%
Registrar
5%
Cancer Statistics
5%
Academic Teaching
5%
Morphological Description
5%
Medicine and Dentistry
Head and Neck Cancer
100%
Comorbidity
100%
Malignant Neoplasm
22%
Lung
18%
Cancer
9%
Overall Survival
9%
Combination Therapy
9%
Neck
9%
Diseases
9%
Neoplasm
4%
Morphology
4%
Medical Record
4%
Prospective Cohort Study
4%
Logistic Regression Analysis
4%
Patient Selection
4%
Log Rank Test
4%
Cancer Statistics
4%
Pharmacology, Toxicology and Pharmaceutical Science
Head and Neck Cancer
100%
Comorbidity
100%
Malignant Neoplasm
27%
Combination Therapy
9%
Overall Survival
9%
Diseases
9%
Neoplasm
4%
Prospective Cohort Study
4%
Cancer Statistics
4%
Immunology and Microbiology
Neck
100%
Comorbidity
100%
Overall Survival
9%
Morphology
4%
Medical Record
4%